Position in NPCE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,335,919
+$758,674 QoQ
Shares Held
84,073
+91.5% QoQ
Ownership
0.245%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 112 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in NPCE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Man Group plc holds $533,295,768 across 39 Medical Devices names. NPCE ranks #22 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,225,164 | $137,649,998 | |
| 2 | EW |
Edwards Lifesciences Corp
|
935,186 | $84,596,924 | |
| 3 | PODD |
Insulet Corp
|
517,217 | $78,746,287 | |
| 4 | ABT |
Abbott Laboratories
|
800,719 | $72,657,242 | |
| 5 | MDT |
Medtronic plc
|
416,155 | $32,555,805 | |
| 6 | DXCM |
Dexcom Inc
|
394,449 | $26,566,138 | |
| 7 | PEN |
Penumbra Inc
|
80,224 | $25,330,727 | |
| 8 | STE |
STERIS plc
|
99,334 | $20,916,760 |
All Filings in NPCE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,335,919 | 84,073 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $577,245 | 43,897 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $333,905 | 21,626 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $203,168 | 19,706 | Shares | Defined | 2025-11-14 | |
| 2024-06-30 | $290,833 | 38,470 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $500,834 | 37,942 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $198,962 | 19,298 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||